Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medivation Inc (NASDAQ:MDVN)

56.95
Delayed Data
As of 4:00pm ET
 -2.31 / -3.90%
Today’s Change
26.41
Today|||52-Week Range
62.94
+17.81%
Year-to-Date
Sanofi's Likely Sweetener for Medivation Panned
Jun 23 / TheStreet.com - Paid Partner Content
BioMarin Takeout Rumors Swirl, Industry Insiders Aren't Convinced
Jun 17 / TheStreet.com - Paid Partner Content
2 Words That Could Bring Down the Entire Prescription Drug Industry
Jun 23 / MotleyFool.com - Paid Partner Content
Medivation's (MDVN) Pidilizumab Positive in Phase I/II Study
Jun 17 / Zacks.com - Paid Partner Content
$18,543 Invested in This Biotech a Decade Ago Is Now Worth $1 Million
Jun 23 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close59.26
Today’s open58.00
Day’s range56.87 - 58.42
Volume6,065,912
Average volume (3 months)3,287,156
Market cap$9.8B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-15.48%
Earnings growth (this year)-28.69%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)+32.76%
P/E ratio38.3
Price/Sales8.68
Price/Book11.13

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-7.10-4.90%
IDXXIDEXX Laboratories I...-3.91-4.27%
RDYDr.Reddy's Laborator...-0.74-1.54%
VRXValeant Pharmaceutic...-1.98-8.90%
Data as of 4:02pm ET, 06/24/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.25
Annual revenue (last year)$943.3M
Annual profit (last year)$244.7M
Net profit margin25.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David T. Hung
Chief Operating Officer
Marion McCourt
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers

Search for Jobs